Gene Therapy

The US Government Hopes $236 Million Will Make Gene Editing Mainstream

The US Government Hopes $236 Million Will Make Gene Editing Mainstream

The first US trial using CRISPR to treat disease in people is imminent, a significant step in testing the true power of gene editing in the clinic. In the future, the US government is hoping that therapies for cancer and other diseases using gene editing will reach a lot more…